Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesThe history of ependymoma management
Child's Nervous System, 05/26/09
Shim K-W et al. - The surgical techniques and assistant modalities for tumor removal are still advancing. So, the outcome of ependymoma is still improving. Unfortunately, newer treatment modalities, such as new chemotherapeutic agent and gene modification agent, are still not promising. The history of ependymoma management is still in progress.
Related Articles
Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade
Journal of Neuro-Oncology, 11/04/09
Relevance Score: 85%
Cervical Ependymoma in a Male Adolescent With Neck and Back Pain
Journal of Manipulative and Physiological Therapeutics, 10/19/09
Relevance Score: 83%
Long-Term Surgical Outcomes for Myxopapillary Ependymomas of the Cauda Equina
Spine, 10/09/09
Relevance Score: 83%
Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: Results of the first UKCCSG/SIOP CNS 9204 trial
European Journal of Cancer, 10/13/09
Relevance Score: 82%
Unique Molecular Characteristics of Pediatric Myxopapillary Ependymoma
Brain Pathology, 10/02/09
Relevance Score: 82%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
Cancer Research, 12/20/09
Acyl-CoA Synthetase VL3 Knockdown Inhibits Human Glioma Cell Proliferation and Tumorigenicity
Cancer Research, 12/20/09
Mutant Metabolic Enzymes Are at the Origin of Gliomas
Cancer Research, 12/20/09
Sponsor
Article Search
Sponsor
Sponsor